Vanguard Group Inc 10x Genomics, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 12,440,060 shares of TXG stock, worth $161 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,440,060
Previous 11,118,086
11.89%
Holding current value
$161 Million
Previous $97.1 Million
48.42%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TXG
# of Institutions
330Shares Held
117MCall Options Held
442KPut Options Held
149K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13.9MShares$180 Million1.33% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$82.8 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.02MShares$78 Million0.04% of portfolio
-
Nikko Asset Management Americas, Inc.6.01MShares$77.9 Million0.74% of portfolio
-
Aqr Capital Management LLC Greenwich, CT4.14MShares$53.6 Million0.04% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.23B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...